Usana Health Sciences shares declined more than -17% Wednesday, following the company’s release of preliminary fiscal second-quarter estimates that fell short of analysts' forecasts.
The multi-level marketer of nutritional products is now expecting second-quarter earnings in the range of 91 cents to 95 cents per share, below the $1.36 a share in the year-earlier period. Analysts polled by FactSet were expecting second-quarter earnings of $1.31 a share.
The company is estimating sales for the quarter to come in within a range of $253 million to $256 million, compared to analysts’ expectations of $307.4 million.
CEO Kevin Guest indicated that weakness in China throughout the second quarter proved to be more challenging for Usana than previously anticipated.
USNA saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on September 09, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 53 instances where the indicator turned negative. In of the 53 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .
The Momentum Indicator moved below the 0 level on September 08, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on USNA as a result. In of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
USNA moved below its 50-day moving average on September 08, 2025 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where USNA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 64 cases where USNA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The 10-day moving average for USNA crossed bullishly above the 50-day moving average on August 26, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where USNA advanced for three days, in of 309 cases, the price rose further within the following month. The odds of a continued upward trend are .
USNA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. USNA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.029) is normal, around the industry mean (38.849). P/E Ratio (16.617) is within average values for comparable stocks, (33.830). Projected Growth (PEG Ratio) (0.978) is also within normal values, averaging (2.732). USNA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.034). P/S Ratio (0.630) is also within normal values, averaging (133.890).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. USNA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Develops and manufactures nutritional, personal care and weight-management products
Industry FoodMajorDiversified